Senior Scientist, Clinical Epidemiology Program
Ottawa Hospital Research Institute
Associate Professor, Department of Medicine
University of Ottawa
Venous thromboembolic disease and cancer, including cancer screening, prevention and management
Dr. Marc Carrier, M.D., MSc, FRCPC, is an Associate Professor in the Faculty of Medicine, Department of Medicine and Scientist in the Clinical Epidemiology Program of The Ottawa Hospital Research Institute. Holds a Tier 2 Research Chair in Venous Thromboembolism and Cancer from the University of Ottawa and New Investigator Award from the Heart and Stroke Foundation of Canada.
Clinical research is focused in venous thromboembolic disease and cancer, including cancer screening, prevention and management. Is currently the Principal Investigator on four peer-reviewed clinical trials (Heart and Stroke Foundation (2) and Canadian Institute of Health Research (2) ) and numerous industry sponsored trials. Has published important systematic reviews and has had multiple international speaking invitations to speak on the topics of cancer and thrombosis.
Castellucci LA, Cameron C, Le Gal G, Rodger MA, Coyle D, Wells PS, Clifford T, Gandara E, Wells G, Carrier M. Clinical and safety outcomes associated with treatment of acute venous thromboembolisme: A systematic review and meta-analysis. JAMA. 2014 Sep;312(11):1122.1135.
Castellucci LA, Cameron C, Le Gal G, Rodger MA, Coyle D, Wells PS, Clifford T, Gandara E, Wells G, Carrier M. Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. BMJ 2013;347:f5133
Diseases, conditions and populations of interest
Cancer; Thrombosis / thromboembolism
Research and clinical approaches